Literature DB >> 28871005

Evaluation of Podoplanin Expression in Hepatocellular Carcinoma Using RNAscope and Immunohistochemistry - A Preliminary Report.

Andreea Cioca1,2, Anca Maria Cimpean3,2, Raluca Amalia Ceausu3,2, Valeria Tarlui2, Alina Toma2, Irina Marin4, Marius Raica3,2.   

Abstract

BACKGROUND: Podoplanin (PDPN), a mucin-type transmembrane glycoprotein, is expressed in a variety of human cancer types, and contributes to tumor progression. Our goal was to evaluate PDPN expression in hepatocellular carcinoma (HCC) using both immunohistochemistry (IHC) and RNAscope in situ hybridization.
MATERIALS AND METHODS: Twenty patients with HCC who underwent partial hepatectomy with curative intent were retrospectively analyzed.
RESULTS: IHC gave positive results in 11 cases, while RNAscope assay for PDPN detected amplification in 16 cases. A significant association was noted between PDPN protein expression and histological tumor grade (p=0.036). Four cases that had negative PDPN results by RNAscope were also negative by IHC, while the remaining five cases with negative results by IHC were positive by RNAscope. A positive relationship was found between PDPN mRNA protein expression (p<0.001).
CONCLUSION: Our preliminary results suggest that PDPN contributes to the malignant potential of HCC. RNAscope proved to be a more sensitive and reliable method than IHC in PDPN detection. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Hepatocellular carcinoma; RNAscope; immunohistochemistry; podoplanin

Mesh:

Substances:

Year:  2017        PMID: 28871005      PMCID: PMC5611524          DOI: 10.21873/cgp.20048

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  18 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  The path to personalized medicine.

Authors:  Margaret A Hamburg; Francis S Collins
Journal:  N Engl J Med       Date:  2010-06-15       Impact factor: 91.245

Review 3.  Real-time PCR for mRNA quantitation.

Authors:  Marisa L Wong; Juan F Medrano
Journal:  Biotechniques       Date:  2005-07       Impact factor: 1.993

4.  Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition.

Authors:  Ester Martín-Villar; Diego Megías; Susanna Castel; Maria Marta Yurrita; Senén Vilaró; Miguel Quintanilla
Journal:  J Cell Sci       Date:  2006-10-17       Impact factor: 5.285

Review 5.  Validating transcripts with probes and imaging technology.

Authors:  Shalev Itzkovitz; Alexander van Oudenaarden
Journal:  Nat Methods       Date:  2011-03-30       Impact factor: 28.547

6.  The global health burden of infection-associated cancers in the year 2002.

Authors:  Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

Review 7.  Podoplanin - a small glycoprotein with many faces.

Authors:  Maciej Ugorski; Piotr Dziegiel; Jaroslaw Suchanski
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

8.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

Authors:  Sean F Altekruse; Katherine A McGlynn; Marsha E Reichman
Journal:  J Clin Oncol       Date:  2009-02-17       Impact factor: 44.544

9.  Low podoplanin expression in pretreatment biopsy material predicts poor prognosis in advanced-stage squamous cell carcinoma of the uterine cervix treated by primary radiation.

Authors:  Kimberly L Dumoff; Christina S Chu; Eleanor E Harris; David Holtz; Xiaowei Xu; Paul J Zhang; Geza Acs
Journal:  Mod Pathol       Date:  2006-05       Impact factor: 7.842

10.  The multifaceted role of podoplanin expression in hepatocellular carcinoma.

Authors:  Andreea Cioca; Amalia R Ceausu; Irina Marin; Marius Raica; Anca M Cimpean
Journal:  Eur J Histochem       Date:  2017-02-13       Impact factor: 3.188

View more
  4 in total

1.  MCLR-elicited hepatic fibrosis and carcinogenic gene expression changes persist in rats with diet-induced nonalcoholic steatohepatitis through a 4-week recovery period.

Authors:  Tarana Arman; J Allen Baron; Katherine D Lynch; Laura A White; Johnny Aldan; John D Clarke
Journal:  Toxicology       Date:  2021-11-02       Impact factor: 4.221

Review 2.  CYP3A4 Gene Is a Novel Biomarker for Predicting a Poor Prognosis in Hepatocellular Carcinoma.

Authors:  Ryo Ashida; Yukiyasu Okamura; Keiichi Ohshima; Yuko Kakuda; Katsuhiko Uesaka; Teiichi Sugiura; Takaaki Ito; Yusuke Yamamoto; Takashi Sugino; Kenichi Urakami; Masatoshi Kusuhara; Ken Yamaguchi
Journal:  Cancer Genomics Proteomics       Date:  2017 Nov-Dec       Impact factor: 4.069

3.  α-Fetoprotein mRNA in situ hybridisation is a highly specific marker of hepatocellular carcinoma: a multi-centre study.

Authors:  Shi-Xun Lu; Yu-Hua Huang; Li-Li Liu; Chris Zhiyi Zhang; Xia Yang; Yuan-Zhong Yang; Chun-Kui Shao; Jian-Ming Li; Dan Xie; Xuchen Zhang; Dhanpat Jain; Jing-Ping Yun
Journal:  Br J Cancer       Date:  2021-04-06       Impact factor: 7.640

4.  Clinical Significance of Fusobacterium nucleatum Infection and Regulatory T Cell Enrichment in Esophageal Squamous Cell Carcinoma.

Authors:  Ning Zhang; Yiwen Liu; Hong Yang; Mengxia Liang; Xiaopeng Wang; Min Wang; Jinyu Kong; Xiang Yuan; Fuyou Zhou
Journal:  Pathol Oncol Res       Date:  2021-07-09       Impact factor: 3.201

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.